I2B2 - Self-Service Data Analytic Tools Training/Education

Needs Statement

i2b2 stands for Informatics for Integrating Biology & the Bedside (i2b2) Cohort Discovery System. Baylor College of Medicine has implemented i2b2 web-based application for BCM Faculty, Staff and Trainees. This allows users to explore for potential research study cohorts with the clinical data acquired from BCM's electronical health record systems (Epic). The purpose of this activity is to increase efficiency and effectiveness of utilizing i2b2 to improve the overall experience of initiating research topic of interest and analyzing data.

Educational Objectives

At the conclusion of this activity, the participant will be able to:

• Utilize SlicerDicer and i2b2 systems and database to generate predictive, prescriptive data and research cohorts
• Improve core datasets with derived and additional data to gain insight
• Identify strategies from SlicerDicer/i2b2 workshops and SlicerDicer/i2b2 Self-Service Data Analytics Tool to refine searches, examine trends, drill down to line-level details quickly to find related records

Target Audience

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.